Why the study?
The prognostic implications of AF and its clinical subtype according to the type of cardiac amyloidosis remain controversial.
Does the presence or subtype of atrial fibrillation impact mortality in patients with cardiac amyloidosis?
Does the presence or subtype of atrial fibrillation impact mortality in patients with cardiac amyloidosis?
In patients with cardiac amyloidosis, neither the presence nor the clinical subtype of atrial fibrillation significantly impacts all-cause or cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
AF history does not worsen adjusted survival in cardiac amyloidosis; leaves open whether subtype or management strategies affect outcomes.
Sanchis et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: